PDA approval of diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, (INFANRIX®) for fifth consecutive DTaP vaccine dose

Morbidity and Mortality Weekly Report

Volumn 52, Issue 38, 2003, Pages 921-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 32544452870     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (4)

1. SmithKline Beecham Biologicals. INFANRIX® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Prescribing information. SmithKline Beecham Biologicals, Rixensart, Belgium, July 2003.
2. CDC. Recommended childhood immunization schedule - United States, 2003, MMWR 2003;52:Q1-Q4.
3. CDC. Pertussis vaccination: use of acellular pertussis vaccine among infants and young children - recommendations of the Advisory Committee on Immunization Practices. MMWR 1997;46(No. RR-7).
4. CDC. Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(No. RR-13).